Oculis Holding AG (OCS) Enterprise Value (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Enterprise Value of -$304.9 million in Q1 2026, down 14.42% quarter-over-quarter from -$266.5 million in Q4 2025, and down 83.07% on a YoY basis from -$1.8 billion in Q1 2025.
Oculis Holding AG (OCS) Enterprise Value (2021 - 2026) Analysis & Trends
Oculis Holding AG's Enterprise Value history runs 6 years deep, the most recent figure standing at -$304.9 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 83.07% year-over-year to -$304.9 million; the TTM figure through Mar 2026 stood at -$304.9 million (down 83.07% YoY), while the FY2025 annual figure was -$266.5 million, down 136.64% from the prior year.
- Enterprise Value was -$304.9 million for Q1 2026 at Oculis Holding AG, down from -$266.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$20.5 million in Q4 2022 to a low of -$304.9 million in Q1 2026.
- Historically, Enterprise Value has averaged -$124.4 million across 5 years, with a median of -$110.5 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value surged 59.08% in 2022, then sank 402.89% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$20.5 million in 2022, then plunged by 301.3% to -$82.4 million in 2023, then sank by 36.65% to -$112.6 million in 2024, then tumbled by 136.64% to -$266.5 million in 2025, then declined by 14.42% to -$304.9 million in 2026.
- The last three Enterprise Value figures came in at -$304.9 million (Q1 2026), -$266.5 million (Q4 2025), and -$158.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -584.73 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | -304.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -304.95 Mn |
| Dec 31, 2025 | -266.52 Mn |
| Sep 30, 2025 | -158.07 Mn |
| Jun 30, 2025 | -193.62 Mn |
| Mar 31, 2025 | -166.57 Mn |
| Dec 31, 2024 | -112.63 Mn |
| Sep 30, 2024 | -124.85 Mn |
| Jun 30, 2024 | -124.29 Mn |
| Mar 31, 2024 | -107.58 Mn |
| Dec 31, 2023 | -82.42 Mn |
| Sep 30, 2023 | -108.30 Mn |
| Jun 30, 2023 | -102.17 Mn |
| Mar 31, 2023 | -21.39 Mn |
| Dec 31, 2022 | -20.54 Mn |
| Sep 30, 2022 | -47.92 Mn |
| Jun 30, 2022 | -48.05 Mn |
| Dec 31, 2021 | -50.19 Mn |